Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer

Lin Cheng, Shichao Zhou, Shaoqing Zhou, Kaixuan Shi, Yan Cheng, Mei-Chun Cai, Kaiyan Ye, Lifeng Lin, Zhenfeng Zhang, Chenqiang Jia, Huaijiang Xiang, Jingyu Zang, Meiying Zhang, Xia Yin, Ying Li, Wen Di, Guanglei Zhuang, Li Tan

Cancer Res (2022) 82 (19): 3588–3602.

https://doi.org/10.1158/0008-5472.CAN-22-0222

Published: 04 October 2022

View articletitled, Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer

Includes: Supplementary data

Journal Articles

Circulating Glioma Cells Exhibit Stem Cell-like Properties

Tianrun Liu, Haineng Xu, Menggui Huang, Wenjuan Ma, Deeksha Saxena, Robert A. Lustig, Michelle Alonso-Basanta, Zhenfeng Zhang, Donald M. O'Rourke, Lin Zhang, Yanqing Gong, Gary D. Kao, Jay F. Dorsey, Yi Fan

Cancer Res (2018) 78 (23): 6632–6642.

https://doi.org/10.1158/0008-5472.CAN-18-0650

Published: 03 December 2018

View articletitled, Circulating Glioma Cells Exhibit Stem Cell-like Properties

Includes: Supplementary data

Journal Articles

Abstract 2033: Identification of a novel genetic abnormality, the amplification of rictor (rapamycin-insensitive companion of mTOR), in a patient with non-small cell lung cancer.

Haiying Cheng, Bilal Piperdi, Edward L. Schwartz, Changcheng Zhu, Zhenfeng Zhang, Balazs Halmos, Vincent Miller, Roman Perez-Soler

Cancer Res (2013) 73 (8_Supplement): 2033.

https://doi.org/10.1158/1538-7445.AM2013-2033

Published: 15 April 2013

View articletitled, Abstract 2033: Identification of a novel genetic abnormality, the amplification of rictor (rapamycin-insensitive companion of mTOR), in a patient with non-small cell lung cancer.

Journal Articles

Abstract 2044: Down-regulation of YAP sensitizes lung cancer cells to platinum and ionizing radiation.

Haiying Cheng, Zhenfeng Zhang, Ruth Rodriguez-Barrueco, Jiyang Yu, Jose M. Silva, Simon Cheng, Roman Perez-Soler, Balazs Halmos

Cancer Res (2013) 73 (8_Supplement): 2044.

https://doi.org/10.1158/1538-7445.AM2013-2044

Published: 15 April 2013

View articletitled, Abstract 2044: Down-regulation of YAP sensitizes lung cancer cells to platinum and ionizing radiation.

Journal Articles

Abstract 4690: PARP inhibition increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancers

Haiying Cheng, Zhenfeng Zhang, Alain Borczuk, Charles A. Powell, Balazs Halmos

Cancer Res (2012) 72 (8_Supplement): 4690.

https://doi.org/10.1158/1538-7445.AM2012-4690

Published: 15 April 2012

View articletitled, Abstract 4690: PARP inhibition increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancers

Journal Articles

Abstract LB-307: Overexpression of AXL as a novel acquired resistance mechanism in EGFR-mutated non-small cell lung cancer cells

Zhenfeng Zhang, Thomas LaFramboise, Mohamed Abdel-Rahman, Alan D. Levine, Patrick C. Ma, Balazs Halmos

Cancer Res (2010) 70 (8_Supplement): LB-307.

https://doi.org/10.1158/1538-7445.AM10-LB-307

Published: 15 April 2010

View articletitled, Abstract LB-307: Overexpression of AXL as a novel acquired resistance mechanism in EGFR-mutated non-small cell lung cancer cells

Journal Articles

Abstract #428: The EGFR-regulated Dual-specificity phosphatase 6 is a negative regulator of oncogenic ERK signaling in lung cancer cells

Zhenfeng Zhang, Susumu Kobayashi, Guosheng Huang, Rom Leidner, Thomas LaFramboise, Alan Levine, Balazs Halmos

Cancer Res (2009) 69 (9_Supplement): 428.

Published: 01 May 2009

View articletitled, Abstract #428: The EGFR-regulated Dual-specificity phosphatase 6 is a negative regulator of oncogenic ERK signaling in lung cancer cells

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer

Circulating Glioma Cells Exhibit Stem Cell-like Properties

Abstract 2033: Identification of a novel genetic abnormality, the amplification of rictor (rapamycin-insensitive companion of mTOR), in a patient with non-small cell lung cancer.

Abstract 2044: Down-regulation of YAP sensitizes lung cancer cells to platinum and ionizing radiation.

Abstract 4690: PARP inhibition increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancers

Abstract LB-307: Overexpression of AXL as a novel acquired resistance mechanism in EGFR-mutated non-small cell lung cancer cells

Abstract #428: The EGFR-regulated Dual-specificity phosphatase 6 is a negative regulator of oncogenic ERK signaling in lung cancer cells

Email alerts

AACR Journals

Update search

Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer

Circulating Glioma Cells Exhibit Stem Cell-like Properties

Abstract 2033: Identification of a novel genetic abnormality, the amplification of rictor (rapamycin-insensitive companion of mTOR), in a patient with non-small cell lung cancer.

Abstract 2044: Down-regulation of YAP sensitizes lung cancer cells to platinum and ionizing radiation.

Abstract 4690: PARP inhibition increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancers

Abstract LB-307: Overexpression of AXL as a novel acquired resistance mechanism in EGFR-mutated non-small cell lung cancer cells

Abstract #428: The EGFR-regulated Dual-specificity phosphatase 6 is a negative regulator of oncogenic ERK signaling in lung cancer cells

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only